A Neoadjuvant Phase IIa Study of Ipilimumab {formerly known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men with Prostate Cancer Followed by Radical Prostatectomy - Stand Up To Cancer

Blog

Posted October 14, 2019

A Neoadjuvant Phase IIa Study of Ipilimumab {formerly known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men with Prostate Cancer Followed by Radical Prostatectomy

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.